Sheng Ding

Research areas

Research interests

Pluripotent Stem Cells Research, CRISPR and Genetic Engineering, 3D Printing in Biomedical Research, Tissue Engineering and Regenerative Medicine, RNA Interference and Gene Delivery

Publications

2026 Cas9 nickase-mediated gene editing enables precise large-fragment integration with minimal byproducts 2026 Dual-targeting pharmacological UFMylation inhibition reprograms tumor and immune microenvironments to achieve long-term glioblastoma regression 2026 Do Larger Models Really Win in Drug Discovery? A Benchmark Assessment of Model Scaling in AI Driven Molecular Property and Activity Prediction 2025 Breast cancer-derived exosomal miR-92a-3p stimulates malignant progression by driving TLR4/NF-κB-mediated macrophage M2 polarization 2025 ALDOA‐Mediated Metabolic Reprogramming is a Targetable Vulnerability for Ferroptosis Sensitization in Cancer